"Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery" by Mark R. Gilbert

Article

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery

Journal of Neuro-oncology (2012)

Mark R. Gilbert, University of Texas MD Anderson Cancer Center
John Kuhn, University of Texas Health Science Center at San Antonio
Kathleen R. Lamborn, University of California, San Francisco
Frank Lieberman, University of Pittsburgh
Patrick Y. Wen, Harvard University
Minesh Mehta, University of Wisconsin-Madison
Timothy Cloughesy, University of California, Los Angeles
Andrew B. Lassman, Memorial Sloan Kettering Cancer Center
Lisa M. DeAngelis, Memorial Sloan Kettering Cancer Center
Susan Chang, University of California, San Francisco
Michael Prados, University of California, San Francisco

Link

Disciplines

Publication Date

January 1, 2012

DOI

10.1007/s11060-011-0650-1

Citation Information

Mark R. Gilbert, John Kuhn, Kathleen R. Lamborn, Frank Lieberman, et al.. "Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery" Journal of Neuro-oncology Vol. 106 Iss. 1 (2012) p. 147 - 153
Available at: http://works.bepress.com/minesh-mehta/322/